Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Filing (Form 4)
Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reports the withholding of 669 common stock shares to cover tax obligations arising from vested restricted stock units.
Summary
- On May 23, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving the company's common stock.
- A total of 669 shares were withheld to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share for the transaction was $21.14.
- Following the transaction, Kim directly owns 217,591 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine tax-related stock transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding procedure related to equity compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it involves a small number of shares withheld for tax purposes.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Date of grant of restricted stock units to Paul Kim. |
| February 27, 2023 | Original report of restricted stock unit grant on Form 4. |
| May 23, 2024 | Date of stock transaction (tax withholding). |
| May 28, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.